Cytokinetics, Incorporated (CYTK) Covered Calls

Cytokinetics, Incorporated covered calls Cytokinetics, Inc.is a clinical-stage biopharmaceutical company, which focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

You can sell covered calls on Cytokinetics, Incorporated to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CYTK (prices last updated Thu 4:16 PM ET):

Cytokinetics, Incorporated (CYTK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
64.80 -2.02 64.50 65.00 934K - 6.9
Covered Calls For Cytokinetics, Incorporated (CYTK)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 65 5.70 59.30 9.6% 152%
Jun 21 65 8.20 56.80 14.4% 90.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Cytokinetics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Its current research and development programs relating to the biology of muscle function are directed to small molecule modulators of the contractility of cardiac, skeletal and smooth muscle. Cytokinetics was founded on August 5, 1997 and is headquartered in South San Francisco, CA.